Chemokine Expression in Human Astrocytes in Response to Shiga Toxin 2
Infection with Shiga toxin- (Stx-) producing Escherichia coli can lead to hemolytic uremic syndrome (HUS). Approximately, 30% of patients with HUS suffer from complications in the central nervous system (CNS), which is an important determinant of mortality in such patients. Autopsy shows mostly edem...
Saved in:
Main Authors: | Naomi Kioka, Koichi Minami, Akira Tamura, Norishige Yoshikawa |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | International Journal of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2012/135803 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Treatment of Shiga-Toxin Hus with Severe Neurologic Features with Eculizumab
by: Jacob H. Umscheid, et al.
Published: (2021-01-01) -
Shiga Toxin-Producing Escherichia coli: Detection, Differentiation, and Implications for Food Safety
by: William J. Zaragoza, et al.
Published: (2016-07-01) -
Shiga Toxin-Producing Escherichia coli: Detection, Differentiation, and Implications for Food Safety
by: William J. Zaragoza, et al.
Published: (2016-07-01) -
Monocytes serve as Shiga toxin carriers during the development of hemolytic uremic syndrome
by: Xinlei Sun, et al.
Published: (2025-01-01) -
Inhibition of tumour necrosis factor alpha by Etanercept attenuates Shiga toxin-induced brain pathology
by: Robin Christ, et al.
Published: (2025-02-01)